Cargando…

Impact of “Killer Immunoglobulin-Like Receptor /Ligand” Genotypes on Outcome following Surgery among Patients with Colorectal Cancer: Activating KIRs Are Associated with Long-Term Disease Free Survival

Approximately 30 % of patients with stage II/III colorectal cancer develop recurrence following surgery. How individual regulation of host mediated anti-tumor cytotoxicity is modified by the killer-cell immunoglobulin-like receptor (KIRs) genotype is essential for prediction of outcome. We analyzed...

Descripción completa

Detalles Bibliográficos
Autores principales:	Beksac, Kemal, Beksac, Meral, Dalva, Klara, Karaagaoglu, Ergun, Tirnaksiz, M. Bulent
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4504472/ https://www.ncbi.nlm.nih.gov/pubmed/26181663 http://dx.doi.org/10.1371/journal.pone.0132526

Ejemplares similares

Role of Killer Immunoglobulin-Like Receptor and Ligand Matching in Donor Selection
por: Beksaç, Meral, et al.
Publicado: (2012)

A model integrating Killer Immunoglobulin-like Receptor (KIR) haplotypes for risk prediction of COVID-19 clinical disease severity
por: Beksac, Meral, et al.
Publicado: (2021)

Retrospective evaluation of pregnant women with celiac disease
por: Beksaç, Kemal, et al.
Publicado: (2017)

Flow Cytometric Aldehyde Dehydrogenase Assay Enables a Fast and Accurate Human Umbilical Cord Blood Hematopoietic Stem Cell Assessment
por: Gençer, Emine Begüm, et al.
Publicado: (2017)

Methylenetetrahydrofolate Reductase Polymorphisms and Pregnancy Outcome
por: Turgal, Mert, et al.
Publicado: (2018)

Natural Killer Cell-Mediated Cellular Therapy of Hematological Malignancies
por: Sahin, Ugur, et al.
Publicado: (2019)

Myeloma as a Second Malignancy following AML: Is a Second Allo Equivalent to Auto?
por: Bakanay, Sule Mine, et al.
Publicado: (2012)

Flow Cytometric Evaluation of Cell Cycle Regulators (Cyclins and Cyclin-Dependent Kinase Inhibitors) Expressed on Bone Marrow Cells in Patients with Chronic Myeloid Leukemia and Multiple Myeloma
por: Toprak, Selami K, et al.
Publicado: (2012)

Genotypic diversity of the Killer Cell Immunoglobulin-like Receptors (KIR) and their HLA class I Ligands in a Saudi population
por: Omar, Suliman Y. Al, et al.
Publicado: (2016)

Ligand specificity of Killer cell Immunoglobulin-like Receptors: a brief history of KIR
por: van Bergen, Jeroen, et al.
Publicado: (2012)

Killer cell immunoglobulin-like receptor (KIR) genes and their HLA ligands in a Brazilian population
por: Cardozo, Daniela Maira, et al.
Publicado: (2023)

Killer Immunoglobulin-like Receptor (KIR) and HLA Genotypes Affect the Outcome of Allogeneic Kidney Transplantation
por: Nowak, Izabela, et al.
Publicado: (2012)

HLA and killer cell immunoglobulin-like receptor (KIRs) genotyping in patients with acute viral encephalitis
por: Tuttolomondo, Antonino, et al.
Publicado: (2018)

HLA and killer cell immunoglobulin-like receptor (KIRs) genotyping in patients with acute ischemic stroke
por: Tuttolomondo, Antonino, et al.
Publicado: (2019)

Diversity of Killer Cell Immunoglobulin-Like Receptor (KIR) Genotypes and KIR2DL2/3 Variants in HCV Treatment Outcome
por: Vidal-Castiñeira, Jose Ramón, et al.
Publicado: (2014)

Distribution of killer cell immunoglobulin-like receptors (KIR) and their HLA-C ligands in two Iranian populations
por: Hiby, Susan E., et al.
Publicado: (2009)

Killer cell immunoglobulin-like receptor (KIR) genes and their HLA-C ligands in a Ugandan population
por: Nakimuli, Annettee, et al.
Publicado: (2013)

Certain Killer Immunoglobulin-Like Receptor (KIR)/KIR HLA Class I Ligand Genotypes Influence Natural Killer Antitumor Activity in Myelogenous Leukemia but Not in Acute Lymphoblastic Leukemia: A Case Control Leukemia Association Study
por: Varbanova, Viktoria Plamenova, et al.
Publicado: (2019)

Editorial: “How to Improve Cord Blood Transplantation: By Enhancing Cell Counts or Engraftment?”
por: Beksac, Meral
Publicado: (2016)

Is There Any Reason to Prefer Cord Blood Instead of Adult Donors for Hematopoietic Stem Cell Transplants?
por: Beksac, Meral
Publicado: (2016)

EXTRAMEDULLARY DISEASE
por: Beksac, Meral
Publicado: (2022)

Killer Cell Immunoglobulin-Like Receptor (KIR) Genotype Distribution in Familial Mediterranean Fever (FMF) Patients
por: Erken, Ertugrul, et al.
Publicado: (2015)

Erratum to: Distribution of killer cell immunoglobulin-like receptors(KIR) and their HLA-C ligands in two Iranian populations
por: Hiby, Susan E., et al.
Publicado: (2010)

Killer Cell Immunoglobulin-Like Receptors (KIRs) Genotype and Haplotype Analysis in Iranians with Non-Melanoma Skin Cancers
por: Yousefinejad, Fahimeh, et al.
Publicado: (2019)

New perspectives on the ligands and function of the killer cell immunoglobulin-like receptor KIR3DL2 in health and disease
por: Shaw, Jacqueline, et al.
Publicado: (2012)

How to Improve Cord Blood Engraftment?
por: Beksac, Meral, et al.
Publicado: (2016)

Killer-Cell Immunoglobulin-Like Receptors (KIR) in HIV-Exposed Infants in Cameroon
por: Luc-Aimé, Kagoué Simeni, et al.
Publicado: (2021)

Treatment of Rectovaginal Fistula Using Sphincteroplasty and Fistulectomy
por: Beksac, Kemal, et al.
Publicado: (2018)

Is Quantification of Measurable Clonal Plasma Cells in Stem Cell Grafts (gMRD) Clinically Meaningful?
por: Cengiz Seval, Guldane, et al.
Publicado: (2022)

Multiple Giant Splenic Artery Aneurysms Causing Sinistral (Left-Sided) Portal Hypertension
por: Beksac, Kemal, et al.
Publicado: (2016)

Vaginoperineal Fistula as a Complication of Perianal Surgery in a Patient with Sjögren's Syndrome: A Case Report
por: Beksac, Kemal, et al.
Publicado: (2014)

Frequency of Killer Cell Immunoglobulin-like Receptors (KIRs) in Korean Patients with Chronic HCV Infection
por: Sung, Pil Soo, et al.
Publicado: (2011)

Killer cell immunoglobulin-like receptor (KIR) gene content variation in the HGDP-CEPH populations
por: Hollenbach, Jill A., et al.
Publicado: (2012)

Effects of the killer immunoglobulin–like receptor (KIR) polymorphisms on HIV acquisition: A meta-analysis
por: Chaisri, Suwit, et al.
Publicado: (2019)

Allele imputation for the killer cell immunoglobulin-like receptor KIR3DL1/S1
por: Harrison, Genelle F., et al.
Publicado: (2022)

Drug Targeting of Genomic Instability in Multiple Myeloma
por: Beksac, Meral, et al.
Publicado: (2020)

NK Cells Expressing the Inhibitory Killer Immunoglobulin-Like Receptors (iKIR) KIR2DL1, KIR2DL3 and KIR3DL1 Are Less Likely to Be CD16+ than Their iKIR Negative Counterparts
por: Isitman, Gamze, et al.
Publicado: (2016)

Double Incomplete Internal Biliary Fistula: Coexisting Cholecystogastric and Cholecystoduodenal Fistula
por: Beksac, Kemal, et al.
Publicado: (2016)

Characterisation of mouse monoclonal antibodies against rhesus macaque killer immunoglobulin-like receptors KIR3D
por: Hermes, Meike, et al.
Publicado: (2012)

The effects of killer cell immunoglobulin-like receptor (KIR) genes on susceptibility to HIV-1 infection in the Polish population
por: Zwolińska, Katarzyna, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_6j4cv4b8flvi6t7uergkcm9uei